<DOC>
	<DOCNO>NCT02002962</DOCNO>
	<brief_summary>The aim randomize study ass effectiveness endomyocardial botulinum toxin injection prevent post-procedural atrial fibrillation patient undergoing radiofrequency ablation atrial flutter .</brief_summary>
	<brief_title>Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only Patients With Atrial Flutter</brief_title>
	<detailed_description />
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age â‰¥ 18 year ECG document paroxysmal persistent AFL No prior document history AF Patient undergo RFA AFL . No indication ( AFL ) continue anticoagulation warfarin . No exist implantable cardiac device ( pacemaker , defibrillator , cardiac resynchronization therapy device ) A history atrial fibrillation Previous AF ablation procedure Congestive heart failure Left Ventricle ejection fraction le 35 % Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>